← Back to Search

Implant

Brown Glaucoma Implant for Glaucoma (Early Bird Trial)

N/A
Waitlist Available
Research Sponsored by MicroOptx
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Early Bird Trial Summary

This trial will study the safety and feasibility of a new implant to lower intraocular pressure in people with glaucoma.

Early Bird Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse Event Rate
Overall Responder Rate
Secondary outcome measures
Alternative Responder Rate
Change in IOP-lowering Medications
Mean Change From Baseline in IOP

Early Bird Trial Design

1Treatment groups
Experimental Treatment
Group I: Brown Glaucoma ImplantExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Brown Glaucoma Implant
2018
N/A
~10

Find a Location

Who is running the clinical trial?

MicroOptxLead Sponsor
2 Previous Clinical Trials
20 Total Patients Enrolled
2 Trials studying Glaucoma
20 Patients Enrolled for Glaucoma
~1 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top